Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Diederik De Cock, Kristien Van der Elst, Sabrina Meyfroidt, Patrick Verschueren & René Westhovens. (2015) The optimal combination therapy for the treatment of early rheumatoid arthritis. Expert Opinion on Pharmacotherapy 16:11, pages 1615-1625.
Read now
Read now
Articles from other publishers (32)
Cătălina-Elena Ionescu, Claudiu Costinel Popescu, Mihaela Agache, Georgiana Dinache & Cătălin Codreanu. (2024) Depression in Rheumatoid Arthritis: Prevalence and Effects on Disease Activity. Journal of Clinical Medicine 13:7, pages 2058.
Crossref
Crossref
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand & Patrick Verschueren. (2023)
Response to: ‘Correspondence on ‘Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial’’ by Jain and Dhir
et al
. Annals of the Rheumatic Diseases 82:7, pages e163-e163.
Crossref
Crossref
Aysun Özlü & Merve Akdeniz Leblebicier. (2022) Does remission in rheumatoid arthritis bring kinesiophobia, quality of life, fatigue, and physical activity closer to normal?. Archives of Rheumatology 37:4, pages 603-612.
Crossref
Crossref
Miyabi Uda, Motomu Hashimoto, Ryuji Uozumi, Mie Torii, Takao Fujii, Masao Tanaka, Moritoshi Furu, Hiromu Ito, Chikashi Terao, Wataru Yamamoto, Genichi Sugihara, Yukako Nakagami, Tsuneyo Mimori & Kazuko Nin. (2021) Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study. Advances in Rheumatology 61:1.
Crossref
Crossref
Fausto Salaffi, Rossella De Angelis, Sonia Farah, Marina Carotti & Marco Di Carlo. (2021) Frailty as a novel predictor of achieving comprehensive disease control (CDC) in rheumatoid arthritis. Clinical Rheumatology 40:12, pages 4869-4877.
Crossref
Crossref
Doxa Papakonstantinou. (2021) Work disability and rheumatoid arthritis: Predictive factors. Work 69:4, pages 1293-1304.
Crossref
Crossref
Martin Bergman, Lili Zhou, Pankaj Patel, Ruta Sawant, Jerry Clewell & Namita Tundia. (2021) Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study. Advances in Therapy 38:5, pages 2558-2570.
Crossref
Crossref
Jiang Minghao Zhao, Xiang Chen, Ke Cheng, Qingming Shi & Kun Peng. (2020) Anserine and glucosamine supplementation attenuates the levels of inflammatory markers in rats with rheumatoid arthritis. AMB Express 10:1.
Crossref
Crossref
Kristien Van der Elst, Patrick Verschueren, Veerle Stouten, Sofia Pazmino, An De Groef, Diederik De Cock, Johan Joly, Philip Moons & René Westhovens. (2019) Patient‐Reported Outcome Data From an Early Rheumatoid Arthritis Trial: Opportunities for Broadening the Scope of Treating to Target. Arthritis Care & Research 71:12, pages 1566-1575.
Crossref
Crossref
Rachel Archer, Emma Hock, Jean Hamilton, John Stevens, Munira Essat, Edith Poku, Mark Clowes, Abdullah Pandor & Matt Stevenson. (2018) Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews. Health Technology Assessment 22:66, pages 1-294.
Crossref
Crossref
Filip Van den Bosch, Philip J Mease, Joachim Sieper, Dominique L Baeten, Yinglin Xia, Su Chen, Aileen L Pangan & In-Ho Song. (2018) Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2. RMD Open 4:1, pages e000566.
Crossref
Crossref
Edward C Keystone, Ferdinand C Breedveld, Désirée van der Heijde, Ronald F van Vollenhoven, Paul Emery, Josef S Smolen, Iain Sainsbury, Stefan Florentinus, Hartmut Kupper, Kun Chen & Arthur Kavanaugh. (2017) Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone. RMD Open 3:2, pages e000445.
Crossref
Crossref
Laura Kuusalo, Kari Puolakka, Hannu Kautiainen, Anna Karjalainen, Timo Malmi, Timo Yli-Kerttula, Marjatta Leirisalo-Repo & Vappu Rantalaiho. (2017) Patient-reported outcomes as predictors of remission in early rheumatoid arthritis patients treated with tight control treat-to-target approach. Rheumatology International 37:5, pages 825-830.
Crossref
Crossref
Patrick Vandormael, Patrick Verschueren, Liesbeth De Winter & Veerle Somers. (2016) cDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis. Immunologic Research 65:1, pages 307-325.
Crossref
Crossref
Patrick Verschueren, Diederik De Cock, Luk Corluy, Rik Joos, Christine Langenaken, Veerle Taelman, Frank Raeman, Isabelle Ravelingien, Klaas Vandevyvere, Jan Lenaerts, Elke Geens, Piet Geusens, Johan Vanhoof, Anne Durnez, Jan Remans, Bert Vander Cruyssen, Els Van Essche, An Sileghem, Griet De Brabanter, Johan Joly, Kristien Van der Elst, Sabrina Meyfroidt & Rene Westhovens. (2015) Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial. Arthritis Research & Therapy 17:1.
Crossref
Crossref
P Verschueren, D De Cock, L Corluy, R Joos, C Langenaken, V Taelman, F Raeman, I Ravelingien, K Vandevyvere, J Lenaerts, E Geens, P Geusens, J Vanhoof, A Durnez, J Remans, B Vander Cruyssen, E Van Essche, A Sileghem, G De Brabanter, J Joly, S Meyfroidt, K Van der Elst & R Westhovens. (2015) Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Annals of the Rheumatic Diseases 74:1, pages 27-34.
Crossref
Crossref
Christian Adrián López-Castillo, Rolando Calderón-Rojas, Jenny Amaya-Amaya, Zayrho DeSanVicente-Célis, Rubén D. Mantilla & Adriana Rojas-Villarraga. (2014) Impact of educational level on rheumatoid arthritis: A systematic review. Revista Colombiana de Reumatología 21:4, pages 201-212.
Crossref
Crossref
Vappu Rantalaiho, Hannu Kautiainen, Markku Korpela, Pekka Hannonen, Oili Kaipiainen-Seppänen, Timo Möttönen, Markku Kauppi, Anna Karjalainen, Kari Laiho, Leena Laasonen, Mikko Hakola, Ritva Peltomaa & Marjatta Leirisalo-Repo. (2014) Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial. Annals of the Rheumatic Diseases 73:11, pages 1954-1961.
Crossref
Crossref
Babak Aberumand, Lillian Barra, Yang Cao, Nicole Le Riche, Andrew E Thompson, Gina Rohekar, Sherry Rohekar, Ashley Bonner & Janet E Pope. (2014) Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor. The Open Rheumatology Journal 8:1, pages 73-76.
Crossref
Crossref
Cheryl Barnabe, Joanne Homik, Susan G. Barr, Liam Martin & Walter P. Maksymowych. (2014) The Effect of Different Remission Definitions on Identification of Predictors of Both Point and Sustained Remission in Rheumatoid Arthritis Treated with Anti-TNF Therapy. The Journal of Rheumatology 41:8, pages 1607-1613.
Crossref
Crossref
Xi Li, Miao Li & Xizhuang Bai. (2014) Upregulation of TLR2 expression is induced by estrogen via an estrogen-response element (ERE). Archives of Biochemistry and Biophysics 549, pages 26-31.
Crossref
Crossref
D. De Cock, G. Vanderschueren, S. Meyfroidt, J. Joly, K. Van der Elst, R. Westhovens & P. Verschueren. (2014) The performance of matrices in daily clinical practice to predict rapid radiologic progression in patients with early RA. Seminars in Arthritis and Rheumatism 43:5, pages 627-631.
Crossref
Crossref
D. De Cock, G. Vanderschueren, S. Meyfroidt, J. Joly, R. Westhovens & P. Verschueren. (2013) Two-year clinical and radiologic follow-up of early RA patients treated with initial step up monotherapy or initial step down therapy with glucocorticoids, followed by a tight control approach: lessons from a cohort study in daily practice. Clinical Rheumatology 33:1, pages 125-130.
Crossref
Crossref
Vasco Crispim Romão, Helena Canhão & João Eurico Fonseca. (2013) Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?. BMC Medicine 11:1.
Crossref
Crossref
Suzanne M.M. Verstappen. (2013) Outcomes of early rheumatoid arthritis – The WHO ICF framework. Best Practice & Research Clinical Rheumatology 27:4, pages 555-570.
Crossref
Crossref
Lauren Mussen, Tristan Boyd, Vivian Bykerk, Faye de Leon, Lihua Li, Gilles Boire, Carol Hitchon, Boulos Haraoui, J. Carter Thorne & Janet Pope. (2012) Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohort. Rheumatology International 33:2, pages 457-465.
Crossref
Crossref
K. Krüger, J. Wollenhaupt, K. Albrecht, R. Alten, M. Backhaus, C. Baerwald, W. Bolten, J. Braun, H. Burkhardt, G. Burmester, M. Gaubitz, A. Gause, E. Gromnica-Ihle, H. Kellner, J. Kuipers, A. Krause, H.-M. Lorenz, B. Manger, H. Nüßlein, H.-G. Pott, A. Rubbert-Roth, M. Schneider, C. Specker, H. Schulze-Koops, H.-P. Tony, S. Wassenberg & U. Müller-Ladner. (2012) S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012German 2012 guidelines for the sequential medical treatment of rheumatoid arthritis. Zeitschrift für Rheumatologie 71:7, pages 592-603.
Crossref
Crossref
Femke HM Prince, Vivian P Bykerk, Nancy A Shadick, Bing Lu, Jing Cui, Michelle Frits, Christine K Iannaccone, Michael E Weinblatt & Daniel H Solomon. (2012) Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis Research & Therapy 14:2, pages R68.
Crossref
Crossref
Andrzej Pawlik, Violetta Dziedziejko, Mateusz Kurzawski, Krzysztof Safranow, Daniel Kotrych & Andrzej Bohatyrewicz. (2012) Effect of ESR1 and ESR2 gene polymorphisms on rheumatoid arthritis treatment with methotrexate. Pharmacological Reports 64:1, pages 185-190.
Crossref
Crossref
P. Verschueren & R. Westhovens. (2011) Optimal care for early RA patients: the challenge of translating scientific data into clinical practice. Rheumatology 50:7, pages 1194-1200.
Crossref
Crossref
E. Hallert, M. Husberg & T. Skogh. (2011) 28-joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project. Rheumatology 50:7, pages 1259-1267.
Crossref
Crossref
J. Kekow, R. Moots, R. Khandker, J. Melin, B. Freundlich & A. Singh. (2010) Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology 50:2, pages 401-409.
Crossref
Crossref